The chemical focus of the CNPD3 is on unique natural products, and the goal is to fully exploit the biosynthetic and therapeutic potential of untapped biodiversity for drug discovery. Candidate compounds are investigated for further development through interactive chemistry and pharmacology efforts. The center embraces all aspects of natural products research from discovery, biosynthesis and chemical synthesis, assay development, screening and target identification to drug development.
CNPD3 FOCUS AND RESEARCH
A New Wave of MEDICINE
In an ocean of possibilities, Dr. Hendrik Luesch is answering the call to make the next great drug discovery. His work takes him below the surface of the sea, where new medicines harbor hope for a healthier tomorrow.
CNPD3 Seminar series
Wednesday, May 17th, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Riley’s presentation is titled “From Seeds to Leads: Transforming Plant Alkaloids into Treatments for Pain and Addiction”
Wednesday, May 10th, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Hopkins presentation is titled “The Development of Selective Kinase Inhibitors to Treat Autoimmune Diseases”
Wednesday, May 3rd, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Thompson’s presentation is titled “Combating Fosfomycin Resistance in Gram-positive Pathogens”
Wednesday, April 12, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Wang’s presentation is titled “Drug Discovery for Patients”
The National Institutes of Health and the National Institute on Drug Abuse awarded a $19 million grant to advance the molecule SBS-518 into a human clinical trial.
The department of medicinal chemistry achieved several major milestones in the 2022-23 academic year.
UF researchers has received a three-year $1.5 million grant from the National Center for Complementary and Integrative Health to conduct a clinical trial on the use of kava as a…
The department of medicinal chemistry held its annual award ceremony to recognizes the top graduate students on Aug. 9.